(818) 431-5208

info@mahealthcareadvisors.com

REFERRAL PROGRAM

BUYER REGISTRATION
  • WHO WE ARE
  • SERVICES
    • Sell Your Company
    • M&A Consultation
    • Expert Valuations
    • Broker-Dealer
  • TRANSACTIONS
  • INSIGHTS
    • The Selling Process
    • The M&A Market
    • M&A Insights Podcast
  • PRESS
  • CONTACT US

Press

We Manage the Sale Process, So You Can Manage Your Business


M&A Problems & Solutions

Big M&A Questions, Part One: “Why Do I Need an Advisor?”

You may have the impression that selling a company is as straightforward as a real estate transaction, but in reality,

April 5, 2024
Read More
Press

Walgreens’ Setback and VillageMD’s Clinic Closures: What Does It Mean?

In recent news, Walgreens Boots Alliance, a major player in the healthcare industry, disclosed a significant development affecting its healthcare

April 3, 2024
Read More
Press

Deciphering the Health Clinic Market: Insights from M&A Advisors

In an enlightening discussion with Levin Associates, Andre Ulloa, Partner and Executive Advisor at M&A Healthcare Advisors, explored the intricacies

March 30, 2024
Read More
Press

2024 Brings New Scrutiny and Oversight to Healthcare M&A

Ulloa suggests that the current environment poses challenges for deal-making, with regulatory headwinds impacting M&A activity… This environment of heightened

March 7, 2024
Read More
The M&A Market

M&A Healthcare Advisors: Looking Ahead to 2024

M&A Healthcare Advisors: Looking Ahead to 2024 12 Active Sellside engagements currently in process 5 transactions are under LOI. 3

February 15, 2024
Read More
The M&A Market

M&A Healthcare Advisors 2023 End Of Year Review

M&A Healthcare Advisors 2023 End of Year Review A slower than average 2023 deal cycle for Private Equity Buyers. Strongest

January 24, 2024
Read More
Press

Understanding the Risks of the 36-Month Rule in Hospice Transactions

As the healthcare landscape continues to evolve, new regulations often present challenges for M&A activity within the industry. The 36-month

December 7, 2023
Read More
Press

Analyzing the Shifts in Home Health and Hospice Market: Insights from M&A Healthcare Advisors

The team at M&A Healthcare Advisors foresee a resurgence in healthcare mergers and acquisitions in 2024, anticipating increased interest from

November 30, 2023
Read More
M&A Pharmacy Market
Press

The Durability of Specialty Pharmacy

While the rest of 2023 may not witness a significant increase in deal volume, Andre Ulloa predicts, “I don’t expect

November 2, 2023
Read More
Press

Private Equity’s Growing Interest in Home Healthcare

“We haven’t seen much private equity activity in the last year or so, only because there’s been a lot of

October 12, 2023
Read More
Load More
(818) 431-5208 | info@mahealthcareadvisors.com | M&A Healthcare Advisors, 4500 Park Granada Blvd, Suite 202, Calabasas, CA 91302
About Transactions Insights Press Contact Us Privacy Policy
Securities are offered through Finalis Securities LLC , Member FINRA / SIPC . M&A Healthcare Advisors is not a registered broker-dealer, and M&A Healthcare Advisors and Finalis Securities LLC are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.
www.mahealthcareadvisors.com (the “M&A Healthcare Advisors Website”) is a website operated by M&A Healthcare Advisors. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy and is subject to change without notice.
Finalis Privacy Policy | Business Continuity Plan | FINRA BrokerCheck | SIPC | Finalis Form CRS
Copyright © 2026 M&A Healthcare Advisors. All rights reserved.

Market Research

The first step in any valuation is to explore what drives value within your specific market segment. In the healthcare sector, understanding industry trends and identifying key market drivers is essential to understanding what makes your business unique.

  • Industry Trends: The healthcare landscape is constantly evolving. Factors such as regulatory changes, technological advancements, reimbursement risk, skilled caregiver supply, and shifts in patient demographics can significantly impact your business’s value. Staying ahead of these trends and adapting your operations accordingly can make your company more attractive to potential buyers in the market.
  • Key Market Drivers: Patient outcomes, cost-efficiency, and specialized services are often critical value drivers in the eyes of a potential acquirer. For example, a company with a track record of delivering better patient outcomes or offering services that are currently in high demand can be factors which elevate your perceived valuation.
  • Identifying Competition and Market Position: Benchmarking your business against competitors or other operator profiles can provide a clearer picture of your market position. This involves analyzing competitor strengths, weaknesses, and growth strategies to highlight your company’s competitive advantage.

Transaction Comparatives

Once we have a solid understanding of your market, we move on to examining recent transactions in the healthcare sector to identify valuation benchmarks.

  • Assessing Comparable Transactions: By analyzing similar deals, we identify comparable businesses that have recently gone through an M&A transaction. This helps us understand the market’s value expectations for companies that operate with a similar profile to your business. While every business is unique, one of the most effective ways to estimate the value of your business is through benchmarking your company with similar companies who have sold in the open market.  With our extensive experience in healthcare M&A, we have transactional comparative data t relative to your business.
  • Market Multiples: One of the key metrics utilized in M&A is the Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) multiple. EBITDA multiples can offer insight into the value of your business based on its profitability. For example, if comparable companies were recently acquired between 5x – 7x EBITDA, this will be one of the reference points we will utilize in determining our opinion of value.
  • Case Study: We’ll also look at recent acquisitions of companies operating in the same segment and size as you. By examining common valuation drivers, financial metrics, and EBITDA multiples, we can draw parallels to your business and refine our opinion of value further.

Financial Analysis

Once we have market and transactional insights, it’s time to perform a detailed analysis of your business’s financial health and growth prospects.

  • Reviewing Financial Health: We analyze key metrics like revenue growth, profit margins, and operating efficiency to assess how well your business is and has been performing. Consistent (or growing) financials can not only boost your valuation in the market but also demonstrate to buyers that your company is a stable and profitable investment.
  • Impact of Assets and Liabilities: Your business’s assets—such as licenses, medical equipment, inventory, entitled real estate, and proprietary technology— may play a role in determining its value. In certain segments, like behavioral health—substance use disorder clinics, it is vital that out-of-network groups have a standardized marketing system for patient acquisition. Conversely, liabilities like outstanding penalties, reimbursement claw backs, charting/clinical data deficiencies, or restrictive contractual obligations can impact the final valuation.  For example, in hospice it is important to have a program to reduce your cap liability and ensure that all patient charts are completed per the current regulatory standards.
  • Projections and Future Cash Flows: In M&A, it’s not just about your current financials; it’s about where your business is headed. We develop grounded financial projections based on current market conditions, historical performance, and growth potential to demonstrate your company’s future cash flow potential.

Conclusion & Findings

After conducting market research and a thorough analysis of your businesses operational, clinical, and financial performance, we compile our findings to deliver a comprehensive valuation reports.

  • Presenting a Valuation Opinion: We summarize all of the data gathered to provide you with a clear opinion of your business’s value. This valuation is supported by concrete data and expert analysis, ensuring transparency and credibility.
  • Next Steps: Once you have a solid understanding of your company’s value, you’ll be in a strong position to pursue your M&A goals. Whether you’re looking to sell now or later, knowing your valuation allows you to plan your next moves more strategically.

Understanding the process of valuation a healthcare company in today’s market is essential if you’re considering any type of capital event in the near future. By exploring key market drivers, examining recent transactions, conducting a thorough financial analysis, and delivering a well-supported valuation, you can approach any M&A related event with confidence.

Going through the steps of conducting a formal valuation not only helps you gain a clear picture of your company’s worth but also provides you with the opportunity to reach maximum value when entering the market to sell or raise capital. Having a third-party, data-driven analysis can equip you with the information and knowledge to successfully navigate a sale process. At M&A Healthcare Advisors, our goal is to guide you through every step of the way, so you can focus on what matters most—growing and transitioning your business successfully.